Document is current
Any future updates will be listed below
-
Authors
Haj-Yehia, Elias
Schulte, Phillip
Fehring, Christian
Korste, Sebastian
Mahabadi, Amir A.
Jurgeleit, Beda
Westendorf, Astrid M.
Hendgen-Cotta, Ulrike B.
Rassaf, Tienush
Totzeck, Matthias
-
Funding
Funding for this research was provided by:
German Research Foundation (HE6317/2-1)
German Research Foundation (RTG 2989)
German Research Foundation (RA969/12-1)
German Cardiac Society (DGK02/2022)
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Received: 19 September 2025
Accepted: 7 June 2026
First Online: 29 June 2026
Declarations
:
: All procedures were in accordance with the ethical standards of the institutional ethics committees of the participating centers and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: E.H.-Y. reports personal fees and others from AstraZeneca, which are outside the submitted work. M.T. and T.R. report personal fees and others from Edwards and Novartis, Bristol Myers Squibb, Bayer, Daiichi Sankyo, and AstraZeneca, which are outside the submitted work. T.R. and U.B.H.-C. cofounded Bimyo, a company focusing on the development of cardioprotective peptides. All other authors declare no conflict of interest.
